Published in Vaccine Weekly, December 20th, 2006
The dogma for treatment of cancer has changed, with the cytotoxic drugs used in chemotherapy regimes set to lose their dominance and be used alongside targeted therapies that are being developed with the aim of more specifically targeting cancer cells.
In this comprehensive report covering targeted therapies in oncology, researchers have analyzed protein kinase inhibitors, antiangiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology.
This extensive 410+ page report compiles...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly